<?xml version="1.0" encoding="UTF-8"?>
<p>All patients were clinically assessed, and blood pressure level and Body Mass Index (BMI) were recorded. Patients having a BMI of &gt;25 kg/m
 <sup>2</sup> were marked as obese, and patients with a BMI of &lt;25 kg/m
 <sup>2</sup> were considered as non-obese. Patients’ blood samples were drawn under fasting conditions, and the accompanying tests, for example, complete blood count (CBC), albumin, total bilirubin, alanine aminotransferase (ALT), aspartate aminotransferase (AST), international normalized ratio (INR), and alpha-fetoprotein (AFP) were performed for diagnosis purpose. Barcelona Clinic Liver Cancer (BCLC) staging and Child-Pugh scores were determined from laboratory tests, and clinical features obtained from diagnostic reports. Patients were categorized into four BCLC stages, for example, Early-stage, A; Intermediate stage, B; Advanced stage, C; and Terminal stage, D. BCLC staging was determined by physician, and patients’ performance status, tumor size and number, Child-Pugh score and portal vein involvement [
 <xref rid="pone.0232121.ref017" ref-type="bibr">17</xref>,
 <xref rid="pone.0232121.ref021" ref-type="bibr">21</xref>] were documented according to EASL guidelines.
</p>
